These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11074745)

  • 21. Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia.
    Milani M; Cimminiello C; Merlo B; Lorena M; Arpaia G; Bonfardeci G
    Am J Cardiol; 1995 Jul; 76(2):51A-53A. PubMed ID: 7604798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.
    Lewis SJ; Sacks FM; Mitchell JS; East C; Glasser S; Kell S; Letterer R; Limacher M; Moye LA; Rouleau JL; Pfeffer MA; Braunwald E
    J Am Coll Cardiol; 1998 Jul; 32(1):140-6. PubMed ID: 9669262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
    Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
    Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
    Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
    Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial.
    Hunt D; Young P; Simes J; Hague W; Mann S; Owensby D; Lane G; Tonkin A
    Ann Intern Med; 2001 May; 134(10):931-40. PubMed ID: 11352694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) study after the Scandinavian Simvastatin Survival Study (4S).
    Tonkin AM
    Am J Cardiol; 1995 Sep; 76(9):107C-112C. PubMed ID: 7572678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.
    Salonen R; Nyyssönen K; Porkkala E; Rummukainen J; Belder R; Park JS; Salonen JT
    Circulation; 1995 Oct; 92(7):1758-64. PubMed ID: 7671358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia.
    Malini PL; Ambrosioni E; De Divitiis O; Di Somma S; Rosiello G; Trimarco B
    Clin Ther; 1991; 13(4):500-10. PubMed ID: 1934003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefits of lipid lowering on vascular reactivity in patients with coronary artery disease and average cholesterol levels: a mechanism for reducing clinical events?
    Cohen JD; Drury JH; Ostdiek J; Finn J; Babu BR; Flaker G; Belew K; Donohue T; Labovitz A
    Am Heart J; 2000 Apr; 139(4):734-8. PubMed ID: 10740160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in cardiovascular risk factors by combined pharmacological and nonpharmacological strategies: the main results of the CELL Study.
    Lindholm LH; Ekbom T; Dash C; Isacsson A; Scherstén B
    J Intern Med; 1996 Jul; 240(1):13-22. PubMed ID: 8708586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group.
    MacMahon S; Sharpe N; Gamble G; Hart H; Scott J; Simes J; White H
    Circulation; 1998 May; 97(18):1784-90. PubMed ID: 9603532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pravastatin use and risk of coronary events and cerebral infarction in japanese men with moderate hypercholesterolemia: the Kyushu Lipid Intervention Study.
    J Atheroscler Thromb; 2000; 7(2):110-21. PubMed ID: 11426582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia.
    Bertolini S; Bon GB; Campbell LM; Farnier M; Langan J; Mahla G; Pauciullo P; Sirtori C; Egros F; Fayyad R; Nawrocki JW
    Atherosclerosis; 1997 Apr; 130(1-2):191-7. PubMed ID: 9126664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty.
    Bertrand ME; McFadden EP; Fruchart JC; Van Belle E; Commeau P; Grollier G; Bassand JP; Machecourt J; Cassagnes J; Mossard JM; Vacheron A; Castaigne A; Danchin N; Lablanche JM
    J Am Coll Cardiol; 1997 Oct; 30(4):863-9. PubMed ID: 9316510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness and safety of low dose pravastatin in elderly hypertensive hypercholesterolemic subjects on antihypertensive therapy.
    Chan P; Lee CB; Lin TS; Ko JT; Pan WH; Lee YS
    Am J Hypertens; 1995 Nov; 8(11):1099-104. PubMed ID: 8554733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of lipid-lowering therapy with pravastatin on myocardial blood flow in young mildly hypercholesterolemic adults.
    Janatuinen T; Laaksonen R; Vesalainen R; Raitakari O; Lehtimäki T; Nuutila P; Knuuti J
    J Cardiovasc Pharmacol; 2001 Oct; 38(4):561-8. PubMed ID: 11588526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemia.
    Santinga JT; Rosman HS; Rubenfire M; Maciejko JJ; Kobylak L; McGovern ME; Behounek BD
    Am J Med; 1994 Jun; 96(6):509-15. PubMed ID: 8017448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial.
    Dupuis J; Tardif JC; Cernacek P; Théroux P
    Circulation; 1999 Jun; 99(25):3227-33. PubMed ID: 10385495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phytosterols dissolved in diacylglycerol oil reinforce the cholesterol-lowering effect of low-dose pravastatin treatment.
    Takeshita M; Katsuragi Y; Kusuhara M; Higashi K; Miyajima E; Mizuno K; Mori K; Obata T; Ohmori R; Ohsuzu F; Onodera Y; Sano J; Sawada S; Tabata S; Tokimitsu I; Tomonobu K; Yamashita T; Yasukawa T; Yonemura A; Nakamura H
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):483-91. PubMed ID: 17964767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.